Autoimmunity BioSolutions Bolsters Leadership Team

ABS is pioneering a personalized, genetically guided immuno-corrective therapy designed to normalize elevated levels of soluble IL7 receptor. HOUSTON, Nov. 19, 2025 /PRNewswire/ -- Autoimmunity BioSolutions (ABS), is pioneering a personalized, genetically guided immuno-corrective therapy...

Read More